Ruling stocks in today’s market: Novo Nordisk A/S (NYSE:NVO)
Novo Nordisk A/S (NYSENVO), from the Healthcare sector exhibited a worth of $ 54.58 today, demonstrating a change in price of 0.42%.
The firm is envisaging an EPS growth of 9.17% in the impending year with an EPS growth of over the next five years will be. Novo Nordisk A/S also displayed an earnings per share growth of 22.50% in the past 5 years.
At present, the ROE is valued at 86.40%, indicating its debt to equity at 0.02. Novo Nordisk A/S shows a total market cap of $ 113434.43, and a gross margin of 85.00% while the profit margin showing 32.10%. The organization’s current ROI is rolling at 85.00%.
Detailed Statistics on Novo Nordisk A/S reveals the following:
The weekly performance is measured at -0.18% with the quarterly performance valued at -4.22%. The monthly performance shows a value of 6.41% alongside the yearly performance of 2.73%. The performance for Year till Date (YTD) currently measures at -4.77%.
Novo Nordisk A/S holds an earnings per share of $ 2.03 and the EPS growth for this year shows a value of 34.00%. The ROI is 85.00% and the return on equity for organization is stated earlier, however, its current value is strolling at 86.40% now.The return on assets (ROA) for Novo Nordisk A/S is 41.50%.
The earnings per share (EPS) is a straightforward measure of an organization’s profit. EPS is measured by subtracting dividends from profits and dividing it by the aggregate volume of shares outstanding.
The return on investment (ROI) is defined to be the amount of money an organization has made or lost in an full-fledged investment – in simple terms.
The return on equity (ROE) calculates the business’s profitability and the efficiency at which it is breeding those profits. ROE is formulated by dividing the total profit by the total amount of money capitalized in the company.
The return on assets (ROA) is an extremely helpful indicator that exhibits how profitable a corporation really is in terms of its total assets. ROA is computed by dividing the total annual earnings by the company’s total assets.
Novo Nordisk A/S holds a dividend yield of 1.77%, and depicts the price/earnings ratio (P/E) to be 26.77. It has a forward P/E ratio of 22.27, and has a price to earnings growth of 2.33. The price to sales growth is 7.01.
Novo Nordisk A/S shows a 52-week low of 20.31% and 52-week high of -7.94%. The corporation holds a 20-day simple moving average of 4.25% with a volume of 4.25%. The average volume floats around 1641.66 at the moment.
The technical stats of Novo Nordisk A/S are as follows:
Novo Nordisk A/S has a simple moving average of 4.25% in its last 20 days. The simple moving average for the past 200 days roll around 0.45%. Novo Nordisk A/S shows a beta of 0.78 with its weekly and monthly volatility valued at 1.37% and 1.57% respectively.